BioMonde

US-based wound care firm BioMonde has launched its patented biosurgical medical device, BioBag, in the US.

The debridement product for patient use is currently available for clinicians across all 50 US states, DC and Puerto Rico.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

BioBag uses all the benefits of biosurgery in an easy-to-use contained dressing and was developed for the debridement of various wounds, including pressure ulcers, neuropathic ulcers, venous stasis ulcers and non-healing traumatic or surgical wounds.

The company said BioBag is currently the only FDA cleared contained biosurgical dressing on the market.

BioMonde product manager Katy Nicell said: "Many of the debridement options currently available do not actively, and selectively, remove bacterial burden and all devitalised tissue from a wound. Biosurgery is unique.

"BioBag allows clinicians to debride wounds with precision, while ensuring containment and patient acceptance."

"The wound size does not increase past the level of damaged tissue and nothing unviable is left behind meaning that effective proliferation can take place."

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

BioBag allows clinicians to debride wounds with precision, while ensuring containment and patient acceptance.

BioMonde CEO Gareth Kempson said: "Historically, bio-surgery was reserved for the most challenging wounds that were not responding to conventional treatment.

"In Europe and the UK, we have proven that the early inclusion of BioBag into the routine debridement practice of non-healing wounds, enables rapid results to be achieved in a cost-efficient manner."

BioMonde manufactured and supplied Larval Therapy in Europe and the UK. The company’s manufacturing facilities are in Bridgend, Wales, Hamburg, Germany and Gainesville, Florida.

Image: BioMonde has launched its patented biosurgical medical device BioBag. Photo: courtesy of Business Wire.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact